Clinical Trial Update: Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial update compares malaria infection levels in HIV-infected infants and children on protease inhibitor–based HAART versus NNRTI-based HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Malaria

Drugs mentioned

• NNRTI-based HAART
• Protease inhibitor-based HAART

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: HIV Infections, Malaria | EARLY_Phase 1 | Status: COMPLETED